Infleqtion Posts Record Q2 Revenue but Shares Drop on Wider Losses and Dilution Concerns
Infleqtion posted record $12.6M Q2 revenue (up 116%) and raised outlook to $43M.
Already have an account? Sign in.
Infleqtion posted record $12.6M Q2 revenue (up 116%) and raised outlook to $43M.
Novartis and Ionis said pelacarsen lowered Lp(a) but failed to cut heart attacks, strokes or deaths in a Phase 3 trial of 8,323 patients.
Canaccord cites tinlarebant as the first drug shown to slow Stargardt lesion growth. The PDUFA date is February 12, 2027.
AMC CEO Adam Aron calls Robinhood’s AMC stock tokens vile and a fake market, demands a halt, and considers an SEC complaint.